These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23104055)

  • 41. New fluorescence-based high-throughput screening assay for small molecule inhibitors of tyrosyl-DNA phosphodiesterase 2 (TDP2).
    Ribeiro CJA; Kankanala J; Shi K; Kurahashi K; Kiselev E; Ravji A; Pommier Y; Aihara H; Wang Z
    Eur J Pharm Sci; 2018 Jun; 118():67-79. PubMed ID: 29574079
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deazaflavin Inhibitors of Tyrosyl-DNA Phosphodiesterase 2 (TDP2) Specific for the Human Enzyme and Active against Cellular TDP2.
    Marchand C; Abdelmalak M; Kankanala J; Huang SY; Kiselev E; Fesen K; Kurahashi K; Sasanuma H; Takeda S; Aihara H; Wang Z; Pommier Y
    ACS Chem Biol; 2016 Jul; 11(7):1925-33. PubMed ID: 27128689
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isoquinoline-1,3-diones as Selective Inhibitors of Tyrosyl DNA Phosphodiesterase II (TDP2).
    Kankanala J; Marchand C; Abdelmalak M; Aihara H; Pommier Y; Wang Z
    J Med Chem; 2016 Mar; 59(6):2734-46. PubMed ID: 26910725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toxoflavins and deazaflavins as the first reported selective small molecule inhibitors of tyrosyl-DNA phosphodiesterase II.
    Raoof A; Depledge P; Hamilton NM; Hamilton NS; Hitchin JR; Hopkins GV; Jordan AM; Maguire LA; McGonagle AE; Mould DP; Rushbrooke M; Small HF; Smith KM; Thomson GJ; Turlais F; Waddell ID; Waszkowycz B; Watson AJ; Ogilvie DJ
    J Med Chem; 2013 Aug; 56(16):6352-70. PubMed ID: 23859074
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses.
    Königer C; Wingert I; Marsmann M; Rösler C; Beck J; Nassal M
    Proc Natl Acad Sci U S A; 2014 Oct; 111(40):E4244-53. PubMed ID: 25201958
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tyrosyl-DNA phosphodiesterase 1 (TDP1) repairs DNA damage induced by topoisomerases I and II and base alkylation in vertebrate cells.
    Murai J; Huang SY; Das BB; Dexheimer TS; Takeda S; Pommier Y
    J Biol Chem; 2012 Apr; 287(16):12848-57. PubMed ID: 22375014
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular mechanisms of topoisomerase 2 DNA-protein crosslink resolution.
    Riccio AA; Schellenberg MJ; Williams RS
    Cell Mol Life Sci; 2020 Jan; 77(1):81-91. PubMed ID: 31728578
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inactivating TDP2 missense mutation in siblings with congenital abnormalities reminiscent of fanconi anemia.
    Zagnoli-Vieira G; Brazina J; Van Den Bogaert K; Huybrechts W; Molenaers G; Caldecott KW; Van Esch H
    Hum Genet; 2023 Sep; 142(9):1417-1427. PubMed ID: 37558815
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tyrosyl-DNA phosphodiesterase (Tdp1) participates in the repair of Top2-mediated DNA damage.
    Nitiss KC; Malik M; He X; White SW; Nitiss JL
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):8953-8. PubMed ID: 16751265
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insights into substrate binding and catalytic mechanism of human tyrosyl-DNA phosphodiesterase (Tdp1) from vanadate and tungstate-inhibited structures.
    Davies DR; Interthal H; Champoux JJ; Hol WG
    J Mol Biol; 2002 Dec; 324(5):917-32. PubMed ID: 12470949
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tyrosyl-DNA phosphodiesterase 2 (Tdp2) repairs DNA-protein crosslinks and protects against double strand breaks
    Anticevic I; Otten C; Popovic M
    Front Cell Dev Biol; 2024; 12():1394531. PubMed ID: 39228401
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery of selective inhibitors of tyrosyl-DNA phosphodiesterase 2 by targeting the enzyme DNA-binding cleft.
    Kossmann BR; Abdelmalak M; Lopez S; Tender G; Yan C; Pommier Y; Marchand C; Ivanov I
    Bioorg Med Chem Lett; 2016 Jul; 26(14):3232-3236. PubMed ID: 27262595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiple Topoisomerase I (TopoI), Topoisomerase II (TopoII) and Tyrosyl-DNA Phosphodiesterase (TDP) inhibitors in the development of anticancer drugs.
    Baglini E; Salerno S; Barresi E; Robello M; Da Settimo F; Taliani S; Marini AM
    Eur J Pharm Sci; 2021 Jan; 156():105594. PubMed ID: 33059042
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TDP2, TOP2, and SUMO: what is ZATT about?
    Zagnoli-Vieira G; Caldecott KW
    Cell Res; 2017 Dec; 27(12):1405-1406. PubMed ID: 29160298
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of the active-site mechanism of tyrosyl-DNA phosphodiesterase I: a member of the phospholipase D superfamily.
    Gajewski S; Comeaux EQ; Jafari N; Bharatham N; Bashford D; White SW; van Waardenburg RC
    J Mol Biol; 2012 Jan; 415(4):741-58. PubMed ID: 22155078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FEN1 participates in repair of the 5'-phosphotyrosyl terminus of DNA single-strand breaks.
    Kametani Y; Takahata C; Narita T; Tanaka K; Iwai S; Kuraoka I
    Carcinogenesis; 2016 Jan; 37(1):56-62. PubMed ID: 26581212
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutation of a conserved active site residue converts tyrosyl-DNA phosphodiesterase I into a DNA topoisomerase I-dependent poison.
    He X; van Waardenburg RCAM; Babaoglu K; Price AC; Nitiss KC; Nitiss JL; Bjornsti MA; White SW
    J Mol Biol; 2007 Sep; 372(4):1070-1081. PubMed ID: 17707402
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro complementation of Tdp1 deficiency indicates a stabilized enzyme-DNA adduct from tyrosyl but not glycolate lesions as a consequence of the SCAN1 mutation.
    Hawkins AJ; Subler MA; Akopiants K; Wiley JL; Taylor SM; Rice AC; Windle JJ; Valerie K; Povirk LF
    DNA Repair (Amst); 2009 May; 8(5):654-63. PubMed ID: 19211312
    [TBL] [Abstract][Full Text] [Related]  

  • 59. WRN protects against topo I but not topo II inhibitors by preventing DNA break formation.
    Christmann M; Tomicic MT; Gestrich C; Roos WP; Bohr VA; Kaina B
    DNA Repair (Amst); 2008 Dec; 7(12):1999-2009. PubMed ID: 18805512
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel Deazaflavin Analogues Potently Inhibited Tyrosyl DNA Phosphodiesterase 2 (TDP2) and Strongly Sensitized Cancer Cells toward Treatment with Topoisomerase II (TOP2) Poison Etoposide.
    Kankanala J; Ribeiro CJA; Kiselev E; Ravji A; Williams J; Xie J; Aihara H; Pommier Y; Wang Z
    J Med Chem; 2019 May; 62(9):4669-4682. PubMed ID: 30998359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.